Author: Pencis

🧬 YULIAN DING, PH.D. – PIONEER IN BIOMEDICAL ENGINEERING AND MACHINE LEARNING

EARLY ACADEMIC PURSUITS🎓

Yulian Ding embarked on her academic journey with a Bachelor of Science in Computer Science from Luoyang Normal University (2010-2014). Her passion for data science and bioinformatics was further solidified during her Master's degree in Computer Science at Shaanxi Normal University (2014-2017), where she focused on dynamic protein complex identification and essential protein identification through swarm intelligence optimization. Her research, under the guidance of Dr. Xiujuan Lei, shaped her understanding of computational biology and bioinformatics. In 2018, Yulian took her academic prowess to the next level by pursuing a Ph.D. in Biomedical Engineering at the University of Saskatchewan (2018-2022). Under the supervision of Dr. Fang-Xiang Wu, she developed advanced machine learning models to predict biomolecule-disease associations, working with miRNAs, lncRNAs, and circRNA.

PROFESSIONAL ENDEAVORS🧑‍🔬

Upon completing her Ph.D., Yulian Ding transitioned into various research roles that leveraged her expertise in both machine learning and biomedical engineering. From March 2022 to February 2023, she served as an Assistant Researcher at the Center for High Performance Computing, Shenzhen Institute of Advanced Technology, under the prestigious Chinese Academy of Sciences. Her work there focused on drug design and disease biomarker identification using machine learning techniques, contributing to major advancements in protein-ligand interaction prediction. Concurrently, Yulian completed a Postdoctoral Fellowship at the University of Saskatchewan’s College of Medicine and Division of Biomedical Engineering. She specialized in bio-data analytics, working on clinical data, particularly in identifying cirRNA biomarkers for cancer.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR BASIS OF GENETIC DISEASE🔬

Yulian Ding’s research focuses on biomedical informatics, particularly at the intersection of machine learning and biomolecular interaction. Her key contributions lie in:

Developing novel machine learning models for predicting disease-associated biomolecules, including miRNAs, lncRNAs, and circRNA.
Drug design and disease biomarker discovery, particularly through the integration of machine learning in protein-ligand interactions.
Enhancing the understanding of bio-data analytics in oncology, utilizing vast datasets to identify crucial molecular targets for treatment.

IMPACT AND INFLUENCE🌍

Ding's work has had significant implications in precision medicine, especially in the early detection of diseases through biomarker identification. Her research on biomolecule-disease associations and the use of machine learning for drug discovery has positioned her as a rising leader in the biomedical engineering field. Her collaboration with leading scientists and institutions, including her postdoctoral work, has influenced both academic research and practical applications in biotechnology.

ACADEMIC CITES📚

Yulian Ding has been recognized for her academic excellence through numerous prestigious awards:

Dr. Victor A. Pollak and Mirka B. Pollak Scholarship (2021, University of Saskatchewan)
Russell (Russ) William Haid Memorial Award (2020, University of Saskatchewan)
China’s National Scholarship for Graduate Students (2017)
China’s National Second Prize of Lanqiao Cup Software Design Competition (2014)
ACM Programming Competition Silver Medal (2014)

Her work has been published in leading academic journals and recognized by international peers in the fields of bioinformatics and computational biology. As a journal reviewer for notable journals like Neurocomputing, Knowledge-Based Systems, and PLOS Computational Biology, she has contributed to shaping future research trends.

LEGACY AND FUTURE CONTRIBUTIONS🔮

Yulian Ding's legacy is deeply intertwined with her pioneering work in biomedical engineering. By harnessing the power of machine learning, she has opened new avenues for disease diagnosis and drug development. Her future endeavors are poised to push the boundaries of biomedical innovation, with a continued focus on applying computational intelligence to solve biomedical challenges. Through ongoing research and collaboration, Yulian will undoubtedly remain at the forefront of biomedical science, contributing to innovations that bridge the gap between computation and medicine.

FINAL THOUGHTS🏅

Yulian Ding's academic journey, professional achievements, and innovative research establish her as a significant figure in biomedical engineering. Her work continues to make impactful contributions to precision medicine and biomedical informatics, shaping the future of healthcare through cutting-edge machine learning applications.

NOTABLE PUBLICATIONS📑

"MRDPDA: A multi-Laplacian regularized deepFM model for predicting piRNA-disease associations"

Authors: Liu, Y. , Zhang, F. , Ding, Y. , Li, J. , Wu, F.-X.
Journal: Cellular and Molecular Medicine
Year: 2024

"P4PC: A Portal for Bioinformatics Resources of piRNAs and circRNAs"

Authors: Liu, Y., Li, R., Ding, Y., Hei, X., Wu, F.-X.
Journal: Bioinformatics
Year: 2024

"Negative sample selection for miRNA-disease association prediction models"

Authors: Ding, Y. , Wang, F. , Zhang, Y. , Wu, F.-X.
Journal: Machine Learning Methods for Multi-Omics Data Integration
Year: 2023

"Biomarker Identification via a Factorization Machine-Based Neural Network With Binary Pairwise Encoding"

Authors: Ding, Y. , Lei, X. , Liao, B. , Wu, F.-X
Journal: IEEE/ACM Transactions on Computational Biology and Bioinformatics
Year: 2023

"MLRDFM: a multi-view Laplacian regularized DeepFM model for predicting miRNA-disease associations"

Authors: Ding, Y. , Lei, X. , Liao, B. , Wu, F.-X
Journal: Briefings in Bioinformatics
Year: 2022

Baoshan Guo | Ultrasoft Laser Dynamics | Best Researcher Award

Posted on 01/10/202401/10/2024 by PencisLeave a Comment

Prof Baoshan Guo | Ultrasoft Laser Dynamics | Best Researcher Award

Beijing Institute of Technology | China

Author Profile

🧬 DR. SHI HAIFENG: A PIONEER IN BIOCHEMISTRY AND METAL TOXICOLOGY

🎓 EARLY ACADEMIC PURSUITS

Dr. Shi Haifeng, born in November 1975, laid the foundation of his scientific career with a Bachelor's Degree in Biochemistry from the Department of Biochemistry, Nanjing University in 1998. Recognized for his academic excellence, he pursued advanced research and earned his Ph.D. in Biochemistry at the Hong Kong University of Science and Technology (HKUST) in 2002, where he studied under the mentorship of Professor Hong Xue. This early education provided him with a deep understanding of biochemical processes and ignited his passion for research in molecular biology.

👨‍🔬 PROFESSIONAL ENDEAVORS

After completing his doctoral degree, Dr. Shi embarked on an impressive career path, starting as a Research Associate at HKUST from 2002 to 2004, contributing significantly to cutting-edge research in Professor Xue’s laboratory. In 2004, he expanded his expertise internationally by serving as a Visiting Scholar at the National Institutes of Health (NIH), USA, in the Liver Diseases Branch of NIDDK, where he remained until 2009. During this time, he developed a profound understanding of metal ion metabolism and its biological toxicity. Dr. Shi returned to China and took up a Professorship at Jiangsu University in 2009, where he became an integral part of the Institute of Life Sciences.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ULTRASOFT LASER DYNAMICS

Dr. Shi’s research stands out in the field of metal ion metabolism and toxicology. He has made groundbreaking contributions to understanding how iron, copper, and cadmium affect human health, particularly in the context of nephropathy caused by heavy metals. His studies on cell-free circulating DNA (cfDNA) have opened new avenues for diagnosing tissue cell damage, furthering the development of non-invasive diagnostics for various diseases. His ability to apply model organisms in his research has provided critical insights into the effects of heavy metal exposure on biological systems.

🌍 IMPACT AND INFLUENCE

With over 70 peer-reviewed publications in international journals, Dr. Shi’s work has garnered significant attention from the global scientific community. One of his papers was selected as a Highly Cited Paper by ESI, while another received notable recognition from Professor Alan Parrish from the University of Missouri-Columbia and was recommended by Faculty Opinions (formerly F1000Prime). This recognition highlights the broad relevance and influence of Dr. Shi’s research. Dr. Shi's international collaborations and contributions during his tenure at NIH have further extended his influence, enabling him to build a global network that enhances his research impact.

📚 ACADEMIC CITATIONS

Dr. Shi Haifeng’s contributions to the field of biochemistry are evidenced by his extensive citation record in the academic community. His papers on metal toxicity and nephropathy models have been widely referenced, contributing to both environmental health and medical research. The high citation rate of his works demonstrates the global relevance of his research findings, cementing his status as a respected researcher in his field.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Shi Haifeng's legacy lies in his pioneering research on heavy metal toxicity and its implications for human health. His efforts in advancing knowledge on cfDNA applications for tissue damage detection represent future potential in non-invasive diagnostic technologies. As a professor and mentor at Jiangsu University, Dr. Shi continues to inspire a new generation of scientists, leaving a lasting impact on the scientific community. Looking forward, Dr. Shi's research on the biological toxicity of metals is likely to expand into new areas, possibly impacting therapeutic developments and environmental safety regulations. His work will continue to contribute to understanding how pollutants affect health, with the potential for policy influence on heavy metal exposure.

📑NOTABLE PUBLICATIONS

"Analysis and optimization of the heat affected zone of CFRP by femtosecond laser processing"

Authors: Chen, M., Guo, B., Jiang, L., Liu, Z., Qian, Q.
Journal: Optics and Laser Technology
Year: 2023

"Strengthened and hydrophobic surface of titanium alloy by femtosecond laser shock peening without a protective or sacrificial layer"

Authors: Hua, Y., Guo, B., Jiang, L., Zhang, T., Chen, M.
Journal: Optics and Laser Technology
Year: 2023

"Lagrangian perspective on the expansion dynamics and shielding effect of femtosecond laser-induced copper plasma plumes"

Authors: Zhan, N., Jiang, L., Zhang, T., Lian, Y., Guo, B.
Journal: Physics of Fluids
Year: 2024

"Ultrafast observation of the abnormal time delay of femtosecond laser pulses in a quartz crystal"

Authors: Guo, B., Zhang, T., Jiang, L.
Journal: Science
Year: 2024

"Active friction-regulated inertia impact piezoelectric actuator"

Authors: Jin, Z., Song, X., Guo, B.
Journal: Heliyon
Year: 2024

Sidra Batool | DNA Sequencing | Women Researcher Award

Posted on 30/09/202430/09/2024 by PencisLeave a Comment

Dr. Sidra Batool | DNA Sequencing | Women Researcher Award

Abdul Wali Khan University Mardan | Pakistan

Author Profile

📜 SIDRA BATOOL: A DEDICATED RESEARCHER AND LEADER

🎓 EARLY ACADEMIC PURSUITS

Sidra Batool, born on January 30, 1997, in Kohat, Khyber Pakhtunkhwa, Pakistan, has pursued a solid academic career. She completed her Matriculation in 2014 with an A1 grade from the BISE Kohat. Continuing her journey, she earned her Intermediate qualification in 2016, achieving an A grade from the BISE Kohat. Her academic foundation, especially in sciences, laid the groundwork for her future research endeavors.

💼 PROFESSIONAL ENDEAVORS

Sidra has demonstrated a diverse range of experiences across academia and business. She has worked as a Research Assistant under Prof. Dr. Sadaf Niaz in the Department of Zoology at Abdul Wali Khan University Mardan. Her key responsibilities included conducting Field Surveys, performing DNA Extraction, PCR Sequencing, and Bioinformatics Analysis. This hands-on experience with advanced laboratory techniques enabled her to contribute significantly to the understanding of tick infestations and related biosecurity measures.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON DNA SEQUENCING

Sidra’s primary research focuses on molecular biology, toxicology, and bioinformatics. Her work emphasizes the taxonomic and molecular characterization of ticks, along with the ecological impacts of various species on livestock. This research is crucial for understanding and controlling tick-borne diseases, especially in rural and under-researched regions of Pakistan. She is proficient in a variety of advanced laboratory techniques, including DNA Extraction, Gel Electrophoresis, PCR, and bioinformatics tools like R Programming, Python, BioEdit, and BEAST. Sidra has also made notable contributions to genomic databases, with several GenBank submissions to her credit, such as OR665376.1, PP565365.1, and PP477083.1.

🌍 IMPACT AND INFLUENCE

Sidra’s research has a direct impact on the field of zoology, particularly in understanding tick infestations and improving livestock health in Pakistan. Her work contributes to sustainable livestock management, helping rural communities mitigate the risks posed by pathogens. Her technical expertise in bioinformatics and molecular biology enables her to explore the genomics of species that directly affect public health and the agricultural economy. Additionally, Sidra’s leadership qualities are evident as she currently manages a team of four, further solidifying her role as a guide and mentor for younger researchers.

🏅 ACADEMIC CITES

Sidra Batool has already started to make her mark in the academic world, with her work receiving citations across various research publications and genomic repositories. Her GenBank submissions and collaborative research papers reflect her growing academic influence. Her participation in conferences and seminars has allowed her to present her findings on a national level, further expanding her recognition in the scientific community.

🏛️ LEGACY AND FUTURE CONTRIBUTIONS

Sidra’s legacy will be defined by her commitment to molecular biology and her efforts to advance research in tick-borne diseases, biosecurity, and ecological conservation. As a young researcher, her potential for contributing to both academic and practical solutions in the field of zoology is immense. In the future, Sidra aspires to expand her research beyond the borders of Pakistan, focusing on international collaborations that address global challenges in zoonotic diseases and biosecurity. With her solid academic background, practical experience, and leadership qualities, she is well-positioned to contribute to global scientific advancements.

✨ PERSONAL SKILLS AND ACHIEVEMENTS

Sidra is proficient in multiple languages, including Pashto, Urdu, and English. Her strong communication skills, both in written and spoken formats, complement her ability to present complex scientific data clearly. She has also garnered a fully funded scholarship through the Ehsaas Undergraduate Scholarship Program for her bachelor’s studies, underscoring her academic excellence. Sidra’s diverse skill set extends to computational tools, where she excels in software like Microsoft Office, FinchTV, Latex, Mesquite, and Figtree, adding value to her research in bioinformatics and computational biology.

📑NOTABLE PUBLICATIONS

“Infestation prevalence, spatio-temporal distribution, phylogenetic positioning, and pathogen investigation of Argas persicus ticks in domestic hens (Gallus gallus domesticus) from Pakistan”

Authors: Tsai, K.-H., Batool, S., Khan, A., Ben Said, M., Khan, A.
Journal: Veterinary Parasitology
Year: 2024

Giulia Pascolini | Neurodevelopmental Disorders | Best Researcher Award

Posted on 30/09/202430/09/2024 by PencisLeave a Comment

Dr. Giulia Pascolini | Neurodevelopmental Disorders | Best Researcher Award

Dermopathic Institute of the Immaculate, IDI-IRCC | Italy

Author Profile

🌟 Biography of Giulia Pascolini, MD, PhD

🎓 EARLY ACADEMIC PURSUITS

Giulia Pascolini's journey in medical science began with a Degree in Medicine from Sapienza University of Rome in 2008, which she completed with honors. Following this, she pursued specialization in Medical Genetics at Tor Vergata University of Rome, graduating with honors in 2015 after five years of in-depth study. Driven by her passion for genetics, Dr. Pascolini went on to earn her Ph.D. in Medical Genetics from Sapienza University in 2019, establishing her expertise in a rapidly advancing field. In 2022, she further expanded her knowledge with a Master of II level in Rare Diseases, also from Sapienza University, solidifying her role as a leading expert in rare genetic disorders.

🩺 PROFESSIONAL ENDEAVORS

Dr. Pascolini's professional career is marked by extensive experience across multiple prestigious institutions. Currently, she is a Clinical Geneticist and head of the Clinical Genetics Service at the Istituto Dermopatico dell'Immacolata (IDI-IRCCS) in Rome, Italy. Since September 2023, she also holds a position as Professor of Medical Genetics at the Faculty of Medicine and Surgery at Tor Vergata University of Rome. Over the years, she has held various roles, including serving as a clinical geneticist at Bambino Gesù Children’s Hospital and a researcher at San Camillo-Forlanini Hospital. Her long-standing commitment to clinical genetics spans over 15 years, with a focus on intellectual disability syndromes, dysmorphology, and developmental disorders.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON NEURODEVELOPMENTAL DISORDERS

Dr. Pascolini's research primarily centers around Developmental Disorders of Chromatin Remodeling (DDCRs), intellectual disability (ID) syndromes, and genodermatoses. She has played a crucial role in the study of the skin phenotype in rare genetic diseases, and her work on deep learning technologies for diagnosing genetic syndromes using facial phenotype recognition is groundbreaking. Her involvement with FDNA Inc. and the DeepGestalt technology is a testament to her contributions to advancing medical genetics through innovative platforms. She is also a principal investigator for multiple research projects, including studies on rare cutaneous tumors and familial melanoma, with funding of over €47,000 for these projects.

🌍 IMPACT AND INFLUENCE

As a Scientific Board Member of the ADNP Syndrome Italian Association and an editorial board member of the Journal of Pediatric Genetics, Dr. Pascolini has made significant contributions to the broader medical community. Her work has helped shape new approaches to the clinical understanding of complex genetic disorders, particularly in rare diseases and neurodevelopmental syndromes. Through her collaborative efforts with international organizations and her academic roles, she continues to influence both current medical practices and future research directions.

📚 ACADEMIC CITES AND PUBLICATIONS

Dr. Pascolini has authored several impactful works, including her involvement in the DeepGestalt technology article on SETD5-associated intellectual disability published in the Journal of Translational Genetics and Genomics. Her contributions to book chapters, such as her writing on Genomic Copy Number Variants (CNVs) and Autism Spectrum Disorder (ASD), have added substantial value to academic literature. Her expertise has also been recognized through invitations to write for special issues in leading journals, enhancing her standing as a key voice in her field.

🏅 AWARDS AND RECOGNITION

In 2019, Dr. Pascolini was awarded the Franca Dagna Bricarelli Award for her clinical research on genetic mutations associated with the BAF complex. This prestigious award highlights her excellence in medical genetics and clinical research. Her contributions to the field, recognized by peers and institutions alike, reflect her profound impact on the study and treatment of genetic disorders.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

With her leadership in clinical genetics, active research on rare skin diseases, and innovative work in genetic syndrome diagnostics, Dr. Pascolini is poised to continue shaping the future of medical genetics. Her contributions to understanding the genetic basis of intellectual disabilities and her work on cutting-edge diagnostic technologies ensure her legacy as a pioneering figure in genetics. As she continues her role in both clinical and academic settings, her future contributions will likely further advance the study and treatment of rare genetic conditions, helping countless individuals worldwide.

📑NOTABLE PUBLICATIONS

"The face of Non-photosensitive trichothiodystrophy phenotypic spectrum: A subsequent study on paediatric population"

Authors: Pascolini, G. , Lipari, M. , Gaudioso, F. , Di Zenzo, G. , Didona, B.
Journal: Molecular Genetics and Genomic Medicine
Year: 2024

"Usmani-Riazuddin syndrome can have a recognizable phenotype: Report of a novel AP1G1 variant"

Authors: Gnazzo, M. , Pascolini, G. , Parlapiano, G. , Novelli, A. , Baban, A.
Journal: Clinical Genetics
Year: 2024

"Extended phenotypic characterization of a novel Helsmoortel-van der Aa syndrome case series"

Authors: Pascolini, G., Di Zenzo, G., Panebianco, A., Didona, B., Gozes, I.
Journal: American Journal of Medical Genetics
Year: 2024

"Ectoderm-derived findings in Aymè-Gripp syndrome"

Authors: Pascolini, G., Di Zenzo, G., Morani, P., Didona, B., Panebianco, A.
Journal: Journal of Dermatology
Year: 2024

"Defining the clinical spectrum of ichthyosis follicularis, atrichia and photophobia clinical association type 1 (IFAP1)"

Authors: Pascolini, G., Fortugno, P., Chandramouli, B., Didona, B., Castiglia, D.
Journal: European Journal of Dermatology
Year: 2023

Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Posted on 26/09/202430/09/2024 by PencisLeave a Comment

Dr. Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Chungna National University | South Korea

Author Profile

BIOGRAPHY OF SANG YEON CHO 🌟

EARLY ACADEMIC PURSUITS 🎓

Sang Yeon Cho embarked on his academic journey at Chungnam National University, where he earned his Bachelor's degree in Biochemistry in 2012. He further pursued an M.S. in Medicine, obtaining his MD degree in 2021. Currently, he is completing his Ph.D. in New Drug Discovery and Development, expected to graduate in February 2025. His strong foundation in the sciences has equipped him with the skills necessary for innovative research in the medical field.

PROFESSIONAL ENDEAVORS 🏥

Currently, Dr. Cho serves as the Vice Director of the Metro Neurosurgery Clinic in Daejeon, South Korea, since October 2022. Prior to this role, he was the Vice Director of Hurisarang Hospital from March 2021 to September 2022. His leadership positions reflect his commitment to advancing medical practice and enhancing patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR CANCER BIOLOGY 🔬

As the Director of ChoLab since 2018, Dr. Cho has focused on cancer genomics and new drug discovery. His research has investigated the molecular mechanisms underlying cancer, emphasizing drug resistance and therapeutic targets. He has actively contributed to several labs, including the Neuroglia Lab and the Nano Primo Research Center, showcasing his multidisciplinary approach to tackling complex medical challenges.

IMPACT AND INFLUENCE 🌍

Dr. Cho's work has significantly influenced the field of medical genetics and cancer research. His publications in high-impact journals highlight the clinical significance of his findings, making substantial contributions to understanding cancer prognosis and treatment. Through his research, he aims to bridge the gap between laboratory discoveries and clinical applications, improving patient outcomes.

ACADEMIC CITATIONS 📚

His research output includes numerous peer-reviewed articles in respected journals such as BMC Medical Genomics, Scientific Reports, and BMC Cancer, where he explores topics like drug resistance, immunotherapy biomarkers, and cancer prognosis. His findings have garnered attention and citations within the academic community, underscoring the relevance and quality of his work.

LEGACY 🏆

Dr. Cho's dedication to advancing cancer research and patient care has already left a mark on the field. His innovative approach, exemplified by multiple patents related to AI in healthcare and cancer diagnostics, positions him as a forward-thinking researcher poised to shape future developments in medical science.

FUTURE CONTRIBUTIONS 🔮

Looking ahead, Dr. Cho aims to continue his research in cancer treatment and drug discovery, integrating cutting-edge technologies like artificial intelligence to enhance therapeutic strategies. With his expected Ph.D. completion in 2025, he is set to further expand his contributions to the field and inspire the next generation of medical researchers.

NOTABLE PUBLICATIONS 📑

"A method for the observation of the primo vascular system in the thoracic duct of a rat"

Authors: Kim, S., Jung, S.J., Cho, S.Y., Soh, K.-S., Kim, S.
Journal: Evidence-based Complementary and Alternative Medicine
Year: 2013

"Protocol for the Observation of the Primo Vascular System in the Lymph Vessels of Rabbits"

Authors: Jung, S.J., Cho, S.Y., Bae, K.-H., ... Song, Y.-K., Soh, K.-S.
Journal: Journal of Acupuncture and Meridian Studies
Year: 2012

Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Posted on 26/09/202405/10/2024 by PencisLeave a Comment

Dr. Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Medical University of South Carolina | United States

Author Profile

🌟 SAMI I. NASSAR: A DEDICATED JOURNEY IN MEDICINE AND RESEARCH

EARLY ACADEMIC PURSUITS 🎓

Sami I. Nassar began his academic journey at Columbia University, where he majored in Neuroscience and Behavior, graduating Cum Laude in 2019 with an impressive GPA of 3.94/4.00. His academic excellence earned him a place in the Psi Chi International Honor Society in Psychology for his outstanding achievements. This strong foundation in neuroscience laid the groundwork for his future medical career. He is currently pursuing his MD at Wayne State University, School of Medicine, where he is on track to graduate in June 2024, having achieved a Step 2 Score of 258—a testament to his dedication to medical excellence.

PROFESSIONAL ENDEAVORS 👨‍⚕️

Throughout his career, Nassar has actively engaged in clinical and research positions across prestigious institutions. His experience as a Research Fellow at the Medical University of South Carolina since 2024 has enabled him to delve into otolaryngological topics, including vertiginous disorders and suicide risk in head and neck cancer patients. At the Henry Ford Health System and Karmanos Cancer Institute, he contributed to significant research on molecular biomarkers and substance use among cancer patients, helping to push the boundaries of cancer research and patient care. His earlier roles, including work at Generation Next Fertility and Columbia University, demonstrate his practical skills in clinical and laboratory settings, offering a holistic approach to patient care and research. These roles also gave him experience in collaborating with medical professionals and managing clinical trials, which have been integral to his development as a medical researcher.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS AND GENOMICS 🔬

Nassar’s research has focused heavily on otolaryngology, head and neck cancer, and HPV-related carcinomas. His work on identifying molecular biomarkers and risk factors in cancer patients, such as those for suicide and substance use, has been groundbreaking. His research not only seeks to understand the molecular foundations of cancer but also aims to improve the quality of life for cancer patients. His investigations into tinnitus and vertiginous disorders add further depth to his research portfolio, contributing to patient outcomes in the field of ear, nose, and throat (ENT) medicine.

IMPACT AND INFLUENCE 🏆

Nassar's research has been widely recognized within the medical community, as seen through numerous awards. His work has been presented at leading conferences, such as the American Head and Neck Society's 11th International Conference, where he won the 3rd place poster award in the Education/Care Delivery category. His earlier recognition by the American Journal of Gastroenterology in 2021 further highlights his ability to contribute to diverse fields of medicine. His influence extends to peer-reviewed academic journals, where his manuscripts and abstracts have garnered attention, solidifying his reputation as a promising researcher.

ACADEMIC CITES 📚

Nassar’s work has been cited in reputable journals, including Cancer Epidemiology, Biomarkers & Prevention, and the American Journal of Gastroenterology. His published work on topics like teduglutide therapy for Short Bowel Syndrome and cancer epidemiology reflects his ability to contribute to high-impact scientific literature. These citations, alongside his ongoing manuscripts on suicide and substance use in cancer patients, illustrate his influence on ongoing medical research.

LEGACY AND FUTURE CONTRIBUTIONS 🌍

As a young and promising researcher, Nassar is poised to make even more significant contributions to the field of medicine. His research on biomarkers and immunochemotherapy for cancer treatment, as well as his ongoing investigation into the psychological aspects of cancer care, will likely have a lasting impact on both academic research and clinical practice. His focus on improving patient quality of life through research on mental health and substance use demonstrates his commitment to a holistic approach to medicine, one that integrates both physical and mental health outcomes. His legacy will undoubtedly include shaping future practices in otolaryngology, head and neck oncology, and biomolecular cancer therapy. With his continued drive and dedication, Nassar’s future contributions to medical science promise to push boundaries and pave the way for innovative treatments and care models.

NOTABLE PUBLICATIONS 📑

"S3030 Safety and Efficacy of Teduglutide Therapy for Management of Short Bowel Syndrome After Intestinal Transplantation"

Authors: Sami I. Nassar; Syed-Mohammed Jafri
Journal: American Journal of Gastroenterology
Year: 2021

"Abstract C067: Disparities in health literacy in patients with head and neck cancer: Considerations for understanding"

Authors: Aleksandra Vidovich; Amy Williams; Samantha H. Tam; Mary K. Miller; Maria Olex; Sami Nassar; Alex Rodriguez; Eric Adjei Boakye
Journal: Cancer Epidemiology, Biomarkers & Prevention
Year: 2023

"The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine"

Authors: Sami I. Nassar; Amber Suk; Shaun A. Nguyen, MD; Dauren Adilbay; John Pang; Cherie-Ann Nathan
Journal: Cancer
Year: 2024

Bassam Al-Naami | Cognitive Neuropsychiatry | Excellence Award(Any Scientific Field)

Posted on 26/09/202426/09/2024 by PencisLeave a Comment

Prof Bassam Al-Naami | Cognitive Neuropsychiatry | Excellence Award(Any Scientific Field)

The Hashemite University | Jordan

Author Profile

📘 BASSAM AL-NAAMI, PH.D. – BIOGRAPHY

🎓 EARLY ACADEMIC PURSUITS

PH.D. IN MEDICAL ELECTRONICS AND ERGONOMICS From 1997 to 2000, Dr. Bassam Al-Naami pursued his Ph.D. at the Saint Petersburg State Electrotechnical University (LETI), Russia. His research was centered on Interaction Efficiency of Operational Virtual Reality Systems with an Operator, a project merging biomedical engineering and television and video engineering. His doctoral work emphasized ergonomics, human factors, and the integration of technology to improve operator interaction in virtual systems. VISITING RESEARCH FELLOWSHIP IN SIGNAL & IMAGE PROCESSING From 2001 to 2003, Dr. Al-Naami completed a Visiting Research Fellowship at the University of Sussex, Brighton, UK. He collaborated with notable researchers, including Dr. John Torry, Dr. Mark English, and Prof. Richard Vincent, focusing on wavelet domain signal processing. DIPLOMA IN BIOMEDICAL ENGINEERING/MEDICAL ELECTRONICS His foundational academic journey began at Stavropol State Technical University, Russia, where he earned a Five-Year Honors Diploma in Biomedical Engineering and Medical Electronics (1992–1997). This laid the groundwork for his future in medical instrumentation and signal processing.

💼 PROFESSIONAL ENDEAVORS

PROFESSOR & DEPARTMENT CHAIR Currently, Dr. Al-Naami holds the position of Professor and Department Chair of Biomedical Engineering at Hashemite University (HU) in Jordan. His career spans over two decades, during which he also served as Vice Dean of Student Affairs (2014–2015) and Dean Assistant of Engineering Faculty (2010–2012). ABET ACCREDITATION LEADER Dr. Al-Naami has been deeply involved in academic accreditation efforts, serving as the ABET Coordinator at Hashemite University. His leadership in developing academic programs, ensuring quality standards, and facilitating ABET accreditation for the Biomedical Engineering department at HU has significantly enhanced the institution’s academic reputation. Additionally, he was pivotal in founding the Master’s Program in Biomedical Engineering at HU during the academic year 2022-2023. ADMINISTRATIVE ROLES & TEACHING Beyond accreditation, Dr. Al-Naami has served on multiple academic committees, contributed to curriculum development, and mentored over 70 final-year engineering projects. He has extensive teaching experience in medical imaging, biomedical instrumentation, and advanced signal processing.

🧬 CONTRIBUTIONS AND RESEARCH FOCUS ON COGNITIVE NEUROPSYCHIATRY

SIGNAL AND IMAGE PROCESSING Dr. Al-Naami's research has a notable focus on signal and image processing in clinical settings, exploring:

ECG, cardiac ischemia, and arrhythmias
Automated detection of sleep apnea
Neurological disorders like Alzheimer’s and multiple sclerosis
Cancer detection via CT and MRI images

MEDICAL INSTRUMENTATION & NON-INVASIVE TECHNOLOGIES He has advanced the development of non-invasive diagnostic tools including devices for:

Hemoglobin measurement
Lung sound analysis
Wound healing automation systems

His pioneering work in field-programmable gate arrays (FPGA) for medical applications has contributed to real-time health monitoring systems. ERGONOMICS & VIRTUAL REALITY Dr. Al-Naami has been at the forefront of ergonomics and virtual reality (VR) research, using haptic devices and VR systems to improve training for medical professionals. His research into the physiological impacts of VR, including visual and muscle fatigue, has influenced both the medical and industrial sectors.

🌍 IMPACT AND INFLUENCE

Dr. Al-Naami’s contributions have significantly impacted medical technology and biomedical engineering across the Middle East and internationally. His leadership in academic accreditation and program development has shaped the next generation of biomedical engineers in Jordan. Through his research, he has improved diagnostic techniques in critical areas such as cancer detection, heart disease, and neurology. His collaboration with global institutions like the University of Sussex and the Jordanian Engineering Association further amplifies his influence.

📊 ACADEMIC CITES

Dr. Al-Naami's work has been widely cited in academic and clinical research papers. His findings on non-invasive medical diagnostics, image processing, and signal analysis are frequently referenced in journals related to biomedical engineering and medical instrumentation.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

AWARDS & RECOGNITION
Dr. Al-Naami has been recognized for his outstanding contributions with multiple accolades, including:

IEEE Senior Membership (2023)
Excellence in Scientific Research Award from Hashemite University (2013/2014)
Best Project Award at Saint Petersburg LETI (1999)

His legacy in shaping the biomedical engineering field through teaching, research, and administrative leadership is remarkable. Moving forward, Dr. Al-Naami aims to continue his research in AI-driven medical diagnostics and expand his work in non-invasive medical devices. FUTURE CONTRIBUTIONS As technology evolves, Dr. Al-Naami’s ongoing projects in deep learning for medical imaging and thermographic analysis for hemoglobin levels will likely redefine diagnostic practices. His focus on IoT in healthcare is set to create innovative solutions for remote patient monitoring and improved healthcare delivery.

📚 TEACHING EXPERIENCE

Dr. Al-Naami has taught a diverse array of undergraduate and postgraduate courses, including:

Biomedical Instrumentation I & II
Medical Imaging Modalities
Digital Image Processing
Medical Device Design & Development

His commitment to education is evident in his student mentorship, advising over 70 final-year projects across biomedical, electrical, and mechanical engineering disciplines.

🔬 RESEARCH PROJECTS

Dr. Al-Naami has spearheaded numerous funded research projects. Key projects include:

Non-invasive hemoglobin measurement using advanced image processing and deep learning
Kidney stone detection using artificial intelligence
Automated hand dexterity monitoring systems for post-stroke patients

His collaborations with institutions such as Al-Bashir Government Hospital and Jordan University Hospital have enhanced clinical research applications in Jordan.

🌟 PROFESSIONAL AFFILIATIONS

Dr. Al-Naami is a Senior Member of IEEE and a member of the Jordanian Engineering Association. He has actively contributed to professional societies, such as the IEEE Engineering in Medicine and Biology Society, playing a vital role in advancing the field of biomedical engineering globally.

📑NOTABLE PUBLICATIONS

"Electromyography Monitoring Systems in Rehabilitation: A Review of Clinical Applications, Wearable Devices and Signal Acquisition Methodologies"

Authors: Al-Ayyad, M. , Owida, H.A. , De Fazio, R. , Al-Naami, B. , Visconti, P.
Journal: Electronics
Year: 2023

"IoT Solutions and AI-Based Frameworks for Masked-Face and Face Recognition to Fight the COVID-19 Pandemic"

Authors: Al-Nabulsi, J. , Turab, N. , Owida, H.A. , ... De Fazio, R. , Visconti, P.
Journal: Sensors
Year: 2023

"Improved recovery of cardiac auscultation sounds using modified cosine transform and LSTM-based masking"

Authors: Al-Zaben, A. , Al-Fahoum, A. , Ababneh, M. , Al-Naami, B. , Al-Omari, G.
Journal: Medical and Biological Engineering and Computing
Year: 2024

"Advanced Low-Pass Filters for Signal Processing: A Comparative Study on Gaussian, Mittag-Leffler, and Savitzky-Golay Filters"

Authors: Rawash, Y.Z. , Al‐Naami, B. , Alfraihat, A. , Owida, H.A.
Journal: Mathematical Modelling of Engineering Problems
Year: 2024

"Automated Lung Cancer Diagnosis Applying Butterworth Filtering, Bi-Level Feature Extraction, and Sparce Convolutional Neural Network to Luna 16 CT Images"

Authors: Gharaibeh, N.Y. , De Fazio, R. , Al-Naami, B. , Al-Hinnawi, A.-R. , Visconti, P.
Journal: Journal of Imaging
Year: 2024

Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

Posted on 25/09/202425/09/2024 by PencisLeave a Comment

Dr. Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

University of Buea | Cameroon

Author Profile